Replenology®
Hair loss solution
Replenology Website
Replenology Website
Replenology Store
Replenology Store
Instructional Leaflet
Document
Instructional Leaflet
21 To Grow™
21 To Grow™
Hair Regrowth Treatment Efficacy and Resistance in Androgenetic Alopecia: A Systematic Review and Bayesian Network Meta-Analysis
Hair Regrowth Treatment Efficacy and Resistance in Androgenetic Alopecia: A Systematic Review and Bayesian Network Meta-Analysis
Background: Androgenetic alopecia (AGA) affects almost half the population, and several treatments intending to regenerate a normal scalp hair phenotype are ...
Women's Clinical Trial Results
Women's Clinical Trial Results
In women with AGA or TE, ALRV5XR treatment significantly increased hair regrowth without adverse events. ALRV5XR displayed a multi-fold improved efficacy and response rate when compared to published trials of standard therapy. Progressive acceleration of TH regrowth suggests regeneration of the structure and function of non-productive telogen follicles and prolonged treatment may restore a normal hair phenotype.
Men's Clinical Trial Results
Men's Clinical Trial Results
ALRV5XR treatment resulted in clinically significant TH regrowth in men with AGA. Furthermore, it appeared to reverse the characteristic hair miniaturisation seen in this condition. When compared to results of published trials of standard therapy, ALRV5XR showed a multi-fold increase both in efficacy and in response rates. In addition, the continuance of TH regrowth from 12 to 24 weeks suggests that the normal structure and function of non-productive telogen follicles is restored and that a normal hair phenotype may be attained by extended ALRV5XR treatment.
Lancet Commentary
Lancet Commentary
Sex differences in clinical trials of ALRV5XR
Sex differences in clinical trials of ALRV5XR
ALRV5XR treatment of androgenetic alopecia (AGA) and telogen effluvium (TE) has early evidence of regenerating a normal scalp hair phenotype in both sexes.De...
Facebook
Facebook
Instagram
Instagram
Email
Email
View on mobile